Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestment Co. Regulatory News (INV)

Share Price Information for Investment Co. (INV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
68.00
Ask:
72.00
Spread: 4.00 (5.882%)
Market Cap: £6.43m
INV Live PriceLast checked at - London Stock Exchange

Intraday Investment Co. Share Chart

Share Split and Total Voting Rights

10 Mar 2025 07:00

RNS Number : 9082Z
Investment Company PLC
10 March 2025
 

 

10 March 2025

 

The Investment Company plc

(the "Company")

LEI 2138004PBWN5WM2XST62

 

Share Split and Total Voting Rights

 

At the Annual General Meeting held on 31 October 2024, the Company's shareholders approved a resolution to sub-divide each of the Company's ordinary shares of 50p each ('Existing Ordinary Shares') into 5 ordinary shares of 10p each ('New Ordinary Shares') (the 'Share Split'). The purpose of the Share Split is to facilitate investment by investors with smaller investment amounts and to enhance the share liquidity and marketability. The Company is now proposing to implement the Share Split, further details of which are set out below.

 

The Share Split is conditional on the New Ordinary Shares being admitted to the Official List of the Financial Conduct Authority ('FCA') and to trading on the London Stock Exchange's main market for listed securities. Applications for such admissions are being made and it is expected that such admissions will become effective, and that dealings in the New Ordinary Shares will commence, at 8.00am on 13 March 2025, at which time the Share Split will become effective. The last day of trading in the Existing Ordinary Shares is expected to be 12 March 2025 and the record date for the Share Split is 6.00pm on that date (the 'Record Date').

 

The Share Split will result in shareholders receiving 5 New Ordinary Shares in exchange for each Existing Ordinary Share held at the Record Date. CREST accounts are expected to be credited with New Ordinary Shares on 13 March 2025 and share certificates in respect of the New Ordinary Shares are expected to be posted to shareholders no later than 27 March 2025.

 

The New Ordinary Shares will have a new ISIN and SEDOL, as follows:

 

New ISIN: GB00BV4FKD05

New SEDOL: BV4FKD0

 

The ticker for the New Ordinary Shares will remain the same as the ticker for the Existing Ordinary Shares (INV). The New Ordinary Shares will rank pari passu with each other and will be subject to the same rights and restrictions (save as to nominal value) as the Existing Ordinary Shares. Each New Ordinary Share will also have one vote per share on a poll. A holding of New Ordinary Shares following the Share Split will represent the same proportion of the issued ordinary share capital of the Company as the corresponding holding of Existing Ordinary Shares immediately prior to the Share Split.

 

The Company currently has 5,584,878 Existing Ordinary Shares in issue (including 3,747,673 Existing Ordinary Shares held in treasury). Immediately following the completion of the Share Split and on the assumption that no Existing Ordinary Shares are bought back or issued by the Company between the date of this announcement and the date on which the Share Split takes effect, the Company will have 27,924,390 New Ordinary Shares in issue (including 18,738,365 New Ordinary Shares held in treasury). 

 

Therefore, following the Share Split, the total number of voting rights in the Company will be 9,186,025, being the New Ordinary Shares (excluding the New Ordinary Shares held in treasury). The figure of 9,186,025 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's voting rights under the FCA's Disclosure Guidance and Transparency Rules.

 

Treasury shares

 

As set at above, the Company currently has 3,747,673 Existing Ordinary Shares held in treasury which, subject to the completion of the Share Split, is expected to result in a total of 18,738,365 New Ordinary Shares held in treasury.

 

In accordance with the authorities granted by shareholders at the Company's last annual general meeting and subject to the UK Listing Rules, the Company is able to sell shares from treasury at a price which is not less than net asset value per New Ordinary Share. The Company has a strong pipeline of investments and would like to raise additional capital to deploy into these investments and may do so through the sale of New Ordinary Shares out of treasury.

 

 

For further information please contact:

ISCA Administration Services Limited (Company Secretary)

01392 487056

Jon Carslake

tic@iscaadmin.co.uk

Shore Capital

020 7601 6128

Gillian Martin / Daphne Zhang (Corporate Advisory)

Henry Willcocks / Fiona Conroy (Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRSSLSUAEISEED
Date   Source Headline
2nd Oct 20242:28 pmRNSNet Asset Value(s)
23rd Sep 20244:10 pmRNSNet Asset Value(s)
19th Sep 20247:00 amRNSFinal Results
17th Sep 20242:37 pmRNSNet Asset Value(s)
10th Sep 202410:26 amRNSNet Asset Value(s)
3rd Sep 20241:48 pmRNSNet Asset Value(s)
27th Aug 20244:47 pmRNSNet Asset Value(s)
19th Aug 20244:04 pmRNSNet Asset Value(s)
13th Aug 20241:17 pmRNSNet Asset Value(s)
6th Aug 20242:04 pmRNSNet Asset Value(s)
30th Jul 20241:18 pmRNSNet Asset Value(s)
23rd Jul 20242:51 pmRNSNet Asset Value(s)
15th Jul 20241:32 pmRNSNet Asset Value(s)
10th Jul 202410:40 amRNSNet Asset Value(s)
8th Jul 20242:27 pmRNSNet Asset Value(s)
25th Jun 202411:05 amRNSNet Asset Value(s)
17th Jun 20244:59 pmRNSNet Asset Value(s)
10th Jun 20244:40 pmRNSNet Asset Value(s)
4th Jun 20244:45 pmRNSNet Asset Value(s)
28th May 20245:03 pmRNSNet Asset Value(s)
21st May 20249:38 amRNSNet Asset Value(s)
14th May 20249:56 amRNSNet Asset Value(s)
7th May 20242:17 pmRNSNet Asset Value(s)
29th Apr 20244:56 pmRNSNet Asset Value(s)
22nd Apr 20245:26 pmRNSNet Asset Value(s)
15th Apr 20244:57 pmRNSNet Asset Value(s)
9th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 20241:29 pmRNSNet Asset Value(s)
25th Mar 20243:37 pmRNSNet Asset Value(s)
19th Mar 20243:33 pmRNSNet Asset Value(s)
12th Mar 20249:58 amRNSNet Asset Value(s)
5th Mar 20242:56 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSHalf-year Report
27th Feb 202412:54 pmRNSNet Asset Value(s)
19th Feb 20244:00 pmRNSNet Asset Value(s)
15th Feb 20244:24 pmRNSDirector Declaration
6th Feb 20241:34 pmRNSNet Asset Value(s)
29th Jan 202410:24 amRNSNet Asset Value(s)
22nd Jan 20245:38 pmRNSNet Asset Value(s)
16th Jan 202410:39 amRNSNet Asset Value(s)
9th Jan 20241:55 pmRNSNet Asset Value(s)
4th Jan 202411:45 amRNSNet Asset Value(s)
27th Dec 20232:08 pmRNSNet Asset Value(s)
18th Dec 20232:11 pmRNSNet Asset Value(s)
12th Dec 20239:32 amRNSNet Asset Value(s)
4th Dec 20231:20 pmRNSNet Asset Value(s)
27th Nov 20233:48 pmRNSNet Asset Value(s)
20th Nov 20233:24 pmRNSNet Asset Value(s)
13th Nov 202310:07 amRNSNet Asset Value(s)
10th Nov 202311:04 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.